Introduction: With the prevalence of DM increasing among rural population in developing countries, factors associated with diabetes and its complications also becomes more important. More than half of diabetic patients with ASB have upper urinary tract involvement and the frequency of symptomatic UTI had been significantly higher. Symptomatic UTIs tends to be more common in diabetic subjects with ASB than in those without ASB. Although ASB is of major concern in diabetic population, the long-term consequences of ASB in patients with DM are poorly documented, Almost all studies were performed among elderly women with type 2 diabetes and there is very little information on the occurrence of ASB among BPL diabetic males in our local setting. Hence in the present study the incidence and etiology of ASB among BPL diabetic male patients was monitored along with the resistance pattern of bacterial isolates to antimicrobial agents. Materials and methods: Clean catch voided midstream urine samples were collected from 1131 BPL Diabetic male patients enrolled for the study. Wet film of centrifuged urine was performed to detect the presence of pus cells, epithelial cells, erythrocytes, microorganisms, cast. Culture was performed using standard loop method and antimicrobial susceptibility of the isolates was studied using Kirby Bauer disc diffusion method following CLSI guidelines. Results: Out of 1131 BPL diabetic male patients screened for ASB, 155 (13.7%) were culture positive. Among the uropathogens Gram negative bacilli was the most commonest type (72.7%) and the most prevalent organisms isolated was Klebsiella spp (35.2%), Enterococcus spp (22.4%), followed by E. coli (19.4 %) ,Pseudomonas aeruginosa ( 7.3%), etc.,. 87.5% of E.coli isolated were ESBL, followed by 77.6 % of Klebsilla spp and 11.1 % Enteroabacter spp. Pseudomonas aeruginosa reported in this study were 100% ESBL and 16.6% Metallo β lactamase (MBL) producers.8.1 % of Vancomycin resistant Enterococcus (VRE) was also found in this study. Conclusion: This study demonstrated a high occurrence of ASB in BPL diabetic males (13.7%). Klebsiella was the most commonest uropathogen found in our study followed by Enterococcus , E.coli and Pseudomonas. E.coli and Pseudomonas showed high rates of drug resistance. Nitrofurantoin and Amikacin was the most effective drugs for majority of the isolates. Hence routine monitoring and screening for ASB in this population is essential. Moreover patients in rural parts of developing countries with diabetes has to be sensitized about the complications of ASB and regarding maintenance of their glycemic control which is of major importance in prevention of the condition.
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Diabetes, a silent epidemic has been diagnosed in about 31.7 million people in the world which comprises 10% of the world's population, where India stands as the "Diabetic Capital" of the world (1) . With the prevalence of both Type I and Type II diabetes increasing worldwide, factors associated with diabetes and its complications also become more important (2) . In 2030 the estimated amount of Diabetes in India is 79.4 million (3, 4) and the prevalence among rural areas of India ranges from 2.4% to 2.7% (5, 6). Poverty is found to be a major risk factor for kidney disease (7) , hypertension (8), diabetes (9), UTI (10 ),etc., Diabetes to little knowledge is just an acute metabolic threat to life, but it actually leads to complications that are life threatening and one such complications is Urinary Tract Infection (UTI) (11). Reports on the association of diabetes mellitus (DM) and urinary tract infections (UTI's) has been increasingly found (12) and UTI being the most important cause of morbidity in these patients (11). UTI's generally commence asymptomatically which leads to the symptomatic phase and may lead to serious complications if not properly managed that requires treatment with antibiotics (13). Upper urinary tract infections and the frequency of symptomatic UTI has been significantly higher in half of diabetic patients with asymptomatic bacteriuria (ASB) (14). Diabetic patients have an increased risk of certain symptomatic UTIs such as pyelonephritis, acute cystitis, emphysematous infections, Candidal infections, renal and perinephric abscess (15). The important clinical concerns of ASB in diabetic individuals are its contribution to morbidity, either the short-term risk of developing a symptomatic UTI and its more serious complications or the longer-term risks of developing serious diabetic complications such as nephropathy (16). Complications of ASB include emphysematous cystitis, pyelonephritis and renal papillary necrosis which occurs more commonly in subjects with type II DM (17). The rate of 30% of ASB is a risk factor for development of pyelonephritis (18) and Symptomatic UTIs tended to be more common i.e., 2.8 % higher in diabetic subjects with ASB than in those without ASB (19). The incidence of ASB in diabetic women varied from 9% -29% and 0.7% -11% in diabetic men (20). Prevalence of ASB is usually 3 times higher in diabetic population compared to non-diabetic population. This is because of the fact that there is metabolic derangement, impaired granulocyte function, neuropathic bladder, increased adherence of bacterial organism to bladder epithelial cells and increased glucose content of urine (21). Moderate and severe glycosuria enhances bacterial growth in-vivo, thereby glycosuria may be one factor contributing to the increased prevalence of the bacteriuria in patients with DM (22) .Uropathogenic bacteria possess specific virulence factors that enhance both invasion and colonization of UTI i.e P-fimbriae of certain strains of E.coli (23, 24). The higher prevalence of UTI in diabetic patients does not appear to be based on the difference in virulence of the causative microorganism but due to differences in host response (24). E.coli being the most common pathogen in ASB with 80% of isolates (25). Infections with other Gramnegative bacilli such as Klebsiella, Pseudomonas aeruginosa and Proteus mirabilis, Enterococcus species, coagulase-negative Staphylococci and fungi like Candida spp, are also common organisms causing UTI in men (26, 27). Antibiotic resistance of uropathogens is increasingly being reported in Diabetic patients with high occurrence of multiple drug resistant strains (28). Higher percentage of resistance to the most commonly prescribed antimicrobials such as Amoxicillin, Nitrofurantoin, Trimethoprim/Sulfamethoxazole and Ciprofloxacin are reported in isolates from diabetic patients (29). Multi-Drug Resistant (MDR) E. coli has also been increasingly reported in UTI (30). Keeping in view the estimated prevalence of DM worldwide, with the increasing burden of DM in the rural areas and the emergence of MDR strains escalating in the developing countries. The only way to thoroughly clarify the significance of ASB in patients with diabetes is to perform high-quality prospective studies on screening and treating ASB (31). Moreover the long-term consequences of ASB in diabetic male patients are poorly documented and there is little data on the occurrence of ASB among Below Poverty Line (BPL) diabetic males in our local setting. Hence with this perspective the present study was undertaken with the objective to determine the incidence and etiology of ASB among BPL diabetic male patients along with the resistance pattern of the bacterial isolates.
MATERIALS
& METHODS A prospective study conducted over a period of 1 year from March 2015 to April 2016 in the Department of Microbiology and Diabetic Outpatient departmentSri Lakshmi Narayana Medical College & Hospital Pondicherry, India. This study was approved by the Institutional Human Ethics Committee and Informed consent was obtained from all participants included in the study. Accordingly all men included in this study were diabetic, BPL card holders of age > 35 years and had not been on any antimicrobials (oral or topical) within the previous 4 weeks. Diabetic male patients with any indwelling urinary tract catheters, history of UTI symptoms dysuria, frequency and urgency, hypertension, known congenital anomalies of urinary tract were excluded from the study. A total of 1131 BPL Diabetic men who attended the diabetic clinic were enrolled in this study. 1131 Clean catch voided midstream urine samples were collected in a sterile wide mouthed culture container from all participants enrolled in this study and it was processed in the microbiology laboratory within 1hr (IDSA 2005) following collection. Microscopic examination of wet film of centrifuged urine was performed to detect the presence of pus cells, epithelial cells, erythrocytes, microorganisms, cast, etc. Urine samples were cultured using standard loop method on to 5%sheep blood agar, MacConkey agar & CLED medium and incubated at 37˚ C for 24hrs and prolonged incubation was done for 48 hrs if there is no growth after 24 hrs. The growth was interpreted as sterile if no growth after 48 hrs, significant if the number of colonies corresponded to 10 5 Colony forming Units (CFU)/ mL, insignificant growth if colony count was less than 10 5 CFU/ mL and Mixed growth if > 2 types of colonies were present (32) 
RESULTS
A total of 1131 BPL diabetic male patients were screened for ASB. Among 1131 patients tested 155 (13.7%) were culture positive and reported to have ASB. Out of 1131 urine samples screened 166 (14.7%) of urine samples showed insignificant bacteriuria, 78 (6.9%) samples showed mixed growth & about 732 (64.7%) samples showed No growth. (Table : 1 ) . Of the 155 cases reported to have ASB, the majority of culture positive cases were in the age group 56 -65 years (45.2%) followed by 66 -75 years (28.4%) and 36 -45 years (14.2 %) while the least (3.9 %) was seen in the age group above 76 years (Table : 2). The distribution of uropathogens isolated from ASB positive cases is listed in (Table : 3) . 
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DISCUSSION
The present study was undertaken to determine the incidence rate and etiology of ASB among BPL Diabetic male patients. This study demonstrated a high occurrence of ASB in BPL diabetic males with an overall incidence of (13.7%). This is in concurrence with many other studies as well (34, 35, 36 The present study was undertaken to determine the incidence rate and etiology of ASB among BPL Diabetic male patients. This study demonstrated a high occurrence of ASB in BPL diabetic males with an This is in concurrence with many other studies as well (34, 35, 36) . In a study from North Indian Type 2 Diabetic Patients the prevalence of ASB in males was 17.3% (37). Whereas in Bharatpur the prevalence of ASB among diabetic males patients was reported to be 5.08% (38). Variations in prevalence have been attributed to factors such as geographical variations, ethnicity of the study participants and variation in the screening tests used (1, 34) . Studies consistently state that Patients with DM have a higher prevalence of ASB and incidence of UTIs compared to patients without DM (39). Patients with DM had 8.7 % bacteremia and urinary tract was the commonest focus for these infections hence UTI in men should be considered complicated (40). It is well understood that lack of awareness about diabetics and its complications, their financial status and lack of time impedes their regular visit to heath care centers which contributes to the higher incidence in this population. Unfortunately, there is very poor awareness about the real dimension of the problem among the BPL male patients. Moreover the risk of end stage renal disease (ESRD) has been found to be increased in individuals with low income and in low income communities ( multiple studies have documented an association of poverty and diabetes with UTI and kidney disease (42, 43, 44, 45, 46) . Hence routine monitoring & screening for ASB in this population is essential.
Klebsiella spp. was the most prevalent pathogen 35.2 % in our study which correlated with earlier published reports of Alebiosu et al., were reported ( 47, 48). However this result was in contrast to majority of published reports where among the gram negative bacilli Escherichia coli prevalent uropathogen isolated in diabetic patients with ASB and UTI (21,31,49,50,51). Pseudomonas was also found to be higher in this study. The predominance of bacteria other than urinary tract is increasingly being reported (28,52). ported to be 5.08% (38). Variations in prevalence have been attributed to factors such as geographical variations, ethnicity of the study participants and variation in the screening tests used (1, 34) . Studies consistently state that a higher prevalence of ASB and incidence of UTIs compared to patients without DM (39). Patients with DM had 8.7 % bacteremia and urinary tract was the commonest focus for these infections hence UTI in men should be considered understood that lack of awareness about diabetics and its complications, their financial status and lack of time impedes their regular visit to heath care centers which contributes to the higher incidence in this population. Unfortunately, oor awareness about the real dimension of the problem among the BPL male patients. Moreover the risk of end stage renal disease (ESRD) has been found to be increased in individuals with low income and in low income communities ( 41) and
have documented an association of poverty and diabetes with UTI and kidney disease Hence routine monitoring & screening for ASB in this population is essential.
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The recent study in Nigeria has reported Staphylococus aureus to be the most common uropathogen in patients with DM (53) .The occurrence of ASB in BPL diabetic male was highest in the age group 56 -65 years, but studies consistently document that the prevalence of ASB is not influenced by the age or type or duration of diabetes (20, 54) . Earlier studies show that symptomatic UTI occurred in 69.2 % of diabetic male patients out of 76.5% of diabetic males with ASB (20). The presence of ASB was found to be the major risk factor for developing symptomatic UTI in diabetic male patients, other risk factors include prostatic syndrome in men (20, 54). Hence further follow up studies are essential to prove or to assess the true incidence of ASB among BPL diabetic males across various age groups and their clinical progression into symptomatic UTI. Moreover there is also inadequate awareness about existing intervention for the prevention of disease in this population.
The antimicrobial sensitivity and resistance pattern differs from each community and each hospital. In our study nitrofurantoin and amikacin was the most effective drugs for the majority of isolates, except 6 isolates of Pseudomonas aeruginosa and 1 isolate of E.coli, which was found resistant to nitrofurantoin. High rates of drug resistance was found in our study with increased percentage of drug resistance shown by Pseudomonas aeruginosa, E.coli &Klebsiella spp. This is in accordance with other studies from developing countries (31, 47, 50, 55, 56 ). This may be due to indiscriminate use of antibiotics or previous exposure of these patients to antibiotics. Treatment of ASB is still an open issue with no clear guidelines. In U.S., the treatment of ASB is recommended, even though specific screening recommendations do not exist whereas in Europe, ASB is not treated (57). However, many of the patients with ASB can progress to symptomatic UTI (34, 58) and UTI in diabetic patients is more likely to cause complications than in nondiabetic patients (59). Hence screening and treatment of ASB in diabetics may be warranted. However more studies and Meta-analysis needs to be done before formulating guidelines and for more successful outcome it is essential to educate this population on ASB, its long term complications and importance of treatment adherence once diagnosed. Early diagnosis and prompt treatment of ASB will definitely pave way to reduce health care related expenditure and morbidity.
Conclusion: The incidence of ASB was found to be higher in BPL diabetic male patients. This is one of the major public health importance. Diabetic patients with ASB have a tendency to progress to symptomatic UTI and develop complications from UTI. Hence screening, monitoring and if needed treatment of these patients on a routine basis may be beneficial in such cases. Majority of the isolates in this study showed increased drug resistance. Therefore there is need to create awareness against antibiotic abuse in this population. Proper glycemic control is also of major importance in prevention of the condition. Moreover patients in rural parts of developing countries with DM has to be sensitized about the complications of ASB & UTI which can lead to dreadful consequences in terms of mortality and morbidity.
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